Phenylpropanolamine
- Generic Name
- Phenylpropanolamine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H13NO
- CAS Number
- 14838-15-4
- Unique Ingredient Identifier
- 33RU150WUN
- Background
Phenylpropanolamine is a sympathomimetic agent that acts as a nonselective adrenergic receptor agonist and norepinephrine reuptake inhibitor. It has been used as a decongestant and appetite suppressant. Currently, it is withdrawn from the market in Canada and the United States due to the risk for hemorrahgic strokes.
- Indication
For the treatment of nasal congestion, control of urinary incontinence, priapism and obesity.
- Associated Conditions
- Allergy-Induced Respiratory Symptoms, Bronchitis, Common Cold, Cough, Nasal Congestion, Rhinorrhoea, Excess mucus or phlegm
- Associated Therapies
- -
Year in Review: 2024 Federal PFAS Roundup
In 2024, EPA designated two PFAS as hazardous under CERCLA, set first federal PFAS drinking water standards, and expanded PFAS reporting. FDA raised PFAS concerns in seafood. GSA banned PFAS in federal contractors' cleaning equipment. DOD granted itself a one-year waiver from PFAS-containing AFFF prohibition.
Evaluation of vascular photobiomodulation for orofacial pain and tension type headache
Long COVID-19 symptoms persist post-recovery, including headache. A trial on VPBM for post-COVID headache showed pain reduction in both VPBM and sham groups, with VPBM showing gradual improvement. However, no significant difference in pain reduction between groups was found, indicating VPBM's potential benefits require further study.
Primary progressive aphasia research updates
Primary progressive aphasia (PPA) significantly impacts quality of life, particularly language abilities, and affects middle-aged individuals and their families. Researchers at the University of Chicago Medicine use the Health Utilities Index to measure PPA's impact and demonstrate telemedicine's feasibility for treatment, overcoming geographic barriers. Despite no cure, these advancements offer hope and practical support.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath